Synergistic Action When GLP-1, GIP, and glucagon receptors are simultaneously activated, their effects are synergistic
Re-measure, document, book
This phase 3b trial evaluates mirikizumab combined with tirzepatide versus mirikizumab with a placebo in adult participants with moderately to severely active CD and comorbid obesity (111)
One factor with any peptide is immunogenicity, which is an unintended immune response to the therapy
This dynamic suggests a future where personalized medicine could play a pivotal role, tailoring treatments to individual patient profiles
Retatrutides glucagon receptor component is thought to be particularly beneficial for liver fat reduction glucagon activation promotes fat mobilisation from the liver as well as from peripheral adipose tissue